V. Bonkoungou

Failing a re-treatment regimen does not predict MDR/XDR tuberculosis: is “blind” treatment dangerous?

A. Matteelli, D. Cirillo, G. Migliori, 2011, European Respiratory Journal.

Systemic exposure to rifampicin in patients with tuberculosis and advanced HIV disease during highly active antiretroviral therapy in Burkina Faso.

A. Matteelli, M. Regazzi, P. Villani, 2012, The Journal of antimicrobial chemotherapy.

Reversible Reduction of Nevirapine Plasma Concentrations During Rifampicin Treatment in Patients Coinfected With HIV-1 and Tuberculosis

A. Matteelli, G. Carosi, M. Regazzi, 2009, Journal of acquired immune deficiency syndromes.